Treatment of advanced epithelial ovarian cancer with cisplatin and cyclophosphamide
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 32 (3) , 336-341
- https://doi.org/10.1016/0090-8258(89)90636-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.Journal of Clinical Oncology, 1986
- A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancerGynecologic Oncology, 1983
- Advanced Ovarian Cancer: A Prospective Randomised Trial of Chlorambucil Versus Combined Cyclophosphamide and Cis-diamminedichloroplatinumAustralian and New Zealand Journal of Medicine, 1982
- CYCLOPHOSPHAMIDE PLUS CIS-PLATINUM IN COMBINATION - TREATMENT PROGRAM FOR STAGE-III OR STAGE-IV OVARIAN-CARCINOMA1982
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- ADVANCED OVARIAN-CANCER - BRIEF INTENSIVE COMBINATION CHEMOTHERAPY AND 2ND-LOOK OPERATION1981
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952